1. Home
  2. AORT vs MDXG Comparison

AORT vs MDXG Comparison

Compare AORT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$44.94

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$7.23

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AORT
MDXG
Founded
1984
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.0B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
AORT
MDXG
Price
$44.94
$7.23
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$49.36
$12.00
AVG Volume (30 Days)
356.3K
774.9K
Earning Date
11-06-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.27
Revenue
$422,646,000.00
$393,442,000.00
Revenue This Year
$15.97
$19.13
Revenue Next Year
$10.96
$2.11
P/E Ratio
N/A
$26.73
Revenue Growth
9.81
14.77
52 Week Low
$21.97
$5.79
52 Week High
$48.04
$9.71

Technical Indicators

Market Signals
Indicator
AORT
MDXG
Relative Strength Index (RSI) 51.19 56.44
Support Level $42.68 $6.62
Resistance Level $46.02 $7.06
Average True Range (ATR) 1.35 0.23
MACD -0.18 0.05
Stochastic Oscillator 53.39 91.11

Price Performance

Historical Comparison
AORT
MDXG

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: